Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$0.87 - $1.36 $568 - $888
653 Added 162.03%
1,056 $1,000
Q1 2022

May 09, 2022

SELL
$1.83 - $3.02 $1,026 - $1,694
-561 Reduced 58.2%
403 $1,000
Q4 2021

Feb 04, 2022

BUY
$2.88 - $4.3 $1,912 - $2,855
664 Added 221.33%
964 $3,000
Q3 2021

Nov 08, 2021

BUY
$3.72 - $5.35 $1,116 - $1,605
300 New
300 $1,000

Others Institutions Holding ZYNE

About Zynerba Pharmaceuticals, Inc.


  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.